BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6148523)

  • 1. "Pap" smear and the risk of cervical neoplasia: quantitative estimates from a case-control study.
    La Vecchia C; Franceschi S; Decarli A; Fasoli M; Gentile A; Tognoni G
    Lancet; 1984 Oct; 2(8406):779-82. PubMed ID: 6148523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barrier methods of contraception and the risk of cervical neoplasia.
    Parazzini F; Negri E; La Vecchia C; Fedele L
    Contraception; 1989 Nov; 40(5):519-30. PubMed ID: 2692961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of cervical neoplasia.
    La Vecchia C
    Biomed Pharmacother; 1985; 39(8):426-33. PubMed ID: 3841750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical neoplasia in pap smears: risk of cervical intra-epithelial neoplasia (CIN) after negative or no prior smears in a population without a mass screening programme.
    Forsmo S; Jacobsen BK; Stalsberg H
    Int J Epidemiol; 1996 Feb; 25(1):53-8. PubMed ID: 8666505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
    Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening practices and invasive cervical cancer risk in different age strata.
    Parazzini F; Negri E; La Vecchia C; Bocciolone L
    Gynecol Oncol; 1990 Jul; 38(1):76-80. PubMed ID: 2354830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative and attributable risk for cervical cancer: a comparative study in the United States and Italy.
    Parazzini F; Hildesheim A; Ferraroni M; La Vecchia C; Brinton LA
    Int J Epidemiol; 1990 Sep; 19(3):539-45. PubMed ID: 2135870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does screening by "Pap" smears help prevent cervical cancer? A case-control study.
    Clarke EA; Anderson TW
    Lancet; 1979 Jul; 2(8132):1-4. PubMed ID: 87887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for cervical intraepithelial neoplasia.
    Parazzini F; La Vecchia C; Negri E; Fedele L; Franceschi S; Gallotta L
    Cancer; 1992 May; 69(9):2276-82. PubMed ID: 1562973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for invasive cervical cancer and reduction of risk by 'Pap' smears in Thai women.
    Wangsuphachart V; Thomas DB; Koetsawang A; Riotton G
    Int J Epidemiol; 1987 Sep; 16(3):362-6. PubMed ID: 3667032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women.
    Castle PE; Wacholder S; Lorincz AT; Scott DR; Sherman ME; Glass AG; Rush BB; Schussler JE; Schiffman M
    J Natl Cancer Inst; 2002 Sep; 94(18):1406-14. PubMed ID: 12237286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrocoagulation and the risk of cervical neoplasia.
    La Vecchia C; Franceschi S; Decarli A; Fasoli M; Gentile A; Gritti P
    Obstet Gynecol; 1985 Nov; 66(5):703-7. PubMed ID: 4058829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organised vs. spontaneous Pap-smear screening for cervical cancer: A case-control study.
    Nieminen P; Kallio M; Anttila A; Hakama M
    Int J Cancer; 1999 Sep; 83(1):55-8. PubMed ID: 10449608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of and attitudes and knowledge about pap smears among women in Kuwait.
    El-Hammasi K; Samir O; Kettaneh S; Al-Fadli A; Thalib L
    J Womens Health (Larchmt); 2009 Nov; 18(11):1825-32. PubMed ID: 19951218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of cervical cancer after a negative Pap smear.
    Viikki M; Pukkala E; Hakama M
    J Med Screen; 1999; 6(2):103-7. PubMed ID: 10444730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
    Açikgöz A; Ergör G
    Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited Pap screening associated with reduced risk of cervical cancer in South Africa.
    Hoffman M; Cooper D; Carrara H; Rosenberg L; Kelly J; Stander I; Williamson AL; Denny L; du Toit G; Shapiro S
    Int J Epidemiol; 2003 Aug; 32(4):573-7. PubMed ID: 12913031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Has the use of pap smears reduced the risk of invasive cervical cancer in Guadalajara, Mexico?
    Jiménez-P rez M; Thomas DB
    Int J Cancer; 1999 Sep; 82(6):804-9. PubMed ID: 10446445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.